Malignant intraductal papillary mucinous neoplasm of the pancreas: In situ versus invasive carcinoma-surgical resectability

被引:44
作者
Vullierme, Marie-Pierre
Giraud-Cohen, Marie
Hammel, Pascal
Sauvanet, Alain
Couvelard, Anne
O'Toole, Dermot
Levy, Philippe
Ruszniewski, Philippe
Vilgrain, Valerie
机构
[1] Beaujon Hosp, Dept Radiol, F-92100 Clichy La Garenne, France
[2] Beaujon Hosp, Dept Pathol, F-92100 Clichy La Garenne, France
[3] Beaujon Hosp, Federat Med Chirurg, F-92100 Clichy La Garenne, France
关键词
D O I
10.1148/radiol.2451060951
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose:To retrospectively evaluate computed tomographic ( CT) findings in patients with in situ and invasive malignant intraductal papillary mucinous neoplasms ( IPMNs) of the pancreas and to evaluate the accuracy for surgical resectability, with surgery and pathologic analysis as the reference standards. Materials and Methods: Institutional review board approval was obtained, and the informed consent requirement was waived. Forty- six patients with malignant IPMN proved at pathologic examination of the surgically resected specimen ( n = 44) or laparotomy ( n = 2) underwent surgery after multidetector CT was performed. CT findings were retrospectively evaluated to determine if a pancreatic malignant IPMN tumor was present; to make this determination, CT criteria were used to differentiate in situ from invasive tumors and signs of unresectability ( liver metastasis, vascular CT pattern of encasement, or regional lymph node metastasis). The extent of the vascular CT pattern of encasement was recorded for each patient ( no obliteration of the fat plane, obliteration of the fat plane of < 50%, or obliteration of the fat plane of >= 50%). Statistical analysis was performed with the x 2 and Student t tests. Results: CT revealed a mural nodule in the pancreatic duct wall in 14 patients with in situ carcinoma and one patient with invasive carcinoma ( P <.003). CT revealed an infiltrative pancreatic mass in 17 patients with invasive carcinoma and two patients with in situ carcinoma ( P <.02). Of the mural nodules, 93% were seen in patients with in situ carcinoma, whereas 90% of infiltrative pancreatic masses were observed in patients with invasive carcinomas. The positive predictive value of CT for determining resectability was 100%, and the overall accuracy of CT for determining resectability and unresectability was 74%. The positive predictive value of CT for determining unresectability was 17%, mainly owing to overestimation of arterial invasion. Conclusion: CT is helpful in the differentiation of in situ and invasive IPMN. Classic vascular invasion criteria lead to the overestimation of surgical tumor unresectability in patients with malignant IPMN.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 40 条
[11]   Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas [J].
Hough, TJ ;
Raptopoulos, V ;
Siewert, B ;
Matthews, JB .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 173 (06) :1509-1512
[12]   An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms [J].
Hruban, RH ;
Takaori, K ;
Klimstra, DS ;
Adsay, NV ;
Albores-Saavedra, J ;
Biankin, AV ;
Biankin, SA ;
Compton, C ;
Fukushima, N ;
Furukawa, T ;
Goggins, M ;
Kato, Y ;
Klöppel, G ;
Longnecker, DS ;
Lüttges, J ;
Maitra, A ;
Offerhaus, GJA ;
Shimizu, M ;
Yonezawa, S .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (08) :977-987
[13]   MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas [J].
Irie, H ;
Honda, H ;
Aibe, H ;
Kuroiwa, T ;
Yoshimitsu, K ;
Shinozaki, K ;
Yamaguchi, K ;
Shimada, M ;
Masuda, K .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (05) :1403-1408
[14]   MDCT of intraductal papillary mucinous neoplasm of the pancreas: Evaluation of features predictive of invasive carcinoma [J].
Kawamoto, S ;
Lawler, LP ;
Horton, KM ;
Eng, J ;
Hruban, RH ;
Fishman, EK .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (03) :687-695
[15]  
Kimura W, 1996, HEPATO-GASTROENTEROL, V43, P692
[16]  
KLOPPEL G, 1996, WO INTERACTION HISTO
[17]   Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes -: Differences in clinical characteristics and surgical management [J].
Kobari, M ;
Egawa, S ;
Shibuya, K ;
Shimamura, H ;
Sunamura, M ;
Takeda, K ;
Matsuno, S ;
Furukawa, T .
ARCHIVES OF SURGERY, 1999, 134 (10) :1131-1136
[18]   Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature [J].
Loftus, EV ;
OlivaresPakzad, BA ;
Batts, KP ;
Adkins, MC ;
Stephens, DH ;
Sarr, MG ;
Dimagno, EP .
GASTROENTEROLOGY, 1996, 110 (06) :1909-1918
[19]   Local staging of pancreatic cancer: Criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT [J].
Lu, DSK ;
Reber, HA ;
Krasny, RM ;
Kadell, BM ;
Sayre, J .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (06) :1439-1443
[20]   Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection.: Comparison with pancreatic ductal adenocarcinoma [J].
Maire, F ;
Hammel, P ;
Terris, B ;
Paye, F ;
Scoazec, JY ;
Cellier, C ;
Barthet, M ;
O'Toole, D ;
Rufat, P ;
Partensky, C ;
Cuillerier, E ;
Lévy, P ;
Belghiti, J ;
Ruszniewski, P .
GUT, 2002, 51 (05) :717-722